Antidepressants bring to blindness

People who are taking certain drugs for depression, may lose vision. Researchers from Canada found that antidepressants belonging to the class of SSRIs increase the risk of developing cataracts.

SSRI Antidepressants   - selective serotonin reuptake inhibitor . This is a tricky definition referred to such popular funds from depression As venlafaxine, milnacipran and duloxetine, which are on average 23% increased risk of Cataract . This is a dangerous eye disease that can cause serious visual disturbances, and even blindness .

However, the study's authors emphasize that these data should not lead to the cessation of use SSRI antidepressants   because of the fear cataracts . Firstly, the risk is not so significant. Secondly, the opticians today have made great strides in the treatment of cataracts. Especially that according to medical risk is justified - some species depression   They are dangerous not only to human health, but also for his life.

However, different SSRI antidepressants   different risks. For example, at the risk of getting taking fluvoxamine   cataracts   It grows by 39%, and the probability of cataract surgery by 51%. People taking venlafaxine average risk of heart disease increases by 33% and 34% operation.

Patients taking paroxetine, the risk of the operation above 23%. But those who use fluosetinom (Prozac), citalopram and sertraline (Zoloft), and the risks of cataract operations do not exceed the average.

Industry News

Go back to the main page